Come along to a free information event on 15 February to learn about breast surgery, body reshaping and abdominoplasty
Some of the principal treatments carried out by Professor Ernest Choy at Spire include:
Treatment of rheumatoid arthritis
I am Head of Rheumatology and Translational Research at the Institute of Infection and Immunity and Director of the Cardiff Regional Experimental Arthritis Treatment and Evaluation (CREATE) Centre at Cardiff University School of Medicine, Cardiff, Wales, UK. I am also Honorary Consultant Rheumatologist at University Hospital of Wales and Clinical Lead of the Welsh Arthritis Research Network (WARN). Previously, I was Reader and Director of the King’s Musculoskeletal Clinical Trials Unit in the Academic Department of Rheumatology, King’s College London.
My major research interest is the treatment of rheumatic diseases focusing on the efficiency of new treatment strategies.
I was Director of Research and Development at King's College Hospital between 2003-2008. I am a member of the European League Against Rheumatism Committee Standing Committee for International Clinical Studies Including Therapeutic Trials. I chair the EULAR Taskforce on developing recommendations for management and classification criteria for fibromyalgia. I have served as clinical expert to the National Institute for Clinical Excellence in the UK and many pharmaceutical companies.
I am a frequent lecturer on the treatment of rheumatic diseases.
|Telephone||029 2073 6011|
|Private secretary||Rebecca David|
|Private secretary email@example.com|
Professor of Rheumatology, Cardiff & Vale University Health Board.
Professor and Head of Rheumatology, Cardiff University.
Back to top
Holds less than 0.1% of the shares in Spire Healthcare Group PLC.Back to top